Ovarian hormones and reproductive risk factors for breast cancer in premenopausal women: The Norwegian EBBA-I study

Human Reproduction

Volumn 26, Issue 6, 2011, Pages 1519-1529

  Iversen, A ^a   Thune, I ^a,b   McTiernan, A ^c   Emaus, A ^b   Finstad, S E ^b   Flote, V ^b   Wilsgaard, T ^a   Lipson, S F ^d   Ellison, P T ^d   Jasienska, G ^e   Furberg, A S ^a,f  

^a UNIVERSITY OF TROMSØ   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c Fred Hutchinson Cancer Research Center   (United States)

^d HARVARD UNIVERSITY   (United States)

^e JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^f UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

Author keywords

17 estradiol; age at first birth; menarche; parity; progesterone

Indexed keywords

ESTRADIOL; ORAL CONTRACEPTIVE AGENT; PROGESTERONE; STEROID;

ADULT; ANTHROPOMETRY; ARTICLE; BIRTH; BREAST CANCER; CANCER RISK; CONTROLLED STUDY; FEMALE; HUMAN; LIFESTYLE; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MENARCHE; MENSTRUAL CYCLE; NORWAY; NULLIPARA; OBESITY; OVARY; PARITY; PREMENOPAUSE; QUESTIONNAIRE; SALIVA ANALYSIS; WAIST CIRCUMFERENCE;

EID: 79957475878     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/der081     Document Type: Article

References (52)

1. Albrektsen G, Heuch I, Thoresen SØ. Histological type and grade of breast cancer tumors by parity, age at birth, and time since birth: A register-based study in Norway. BMC Cancer 2010;10:226.
2. Apter D, Reinila M, Vihko R. Some endocrine characteristics of early menarche, a risk factor for breast cancer, are preserved into adulthood. Int J Cancer 1989;44:783-787. (Pubitemid 20007972)
3. Ballard Barbash R, Friedenreich C, Slattery M, Thune I. Obesity and Body Composition. Cancer Epidemiology and Prevention, 3rd edn. New York, NY: Oxford University Press, 2006.
4. Bernstein L, Pike MC, Ross RK, Henderson BE. Age at menarche and estrogen concentrations of adult women. Cancer Causes and Control 1991;2:221-225.
5. Berstad P, Coates RJ, Bernstein L, Folger SG, Malone KE, Marchbanks PA, Weiss LK, Liff JM, McDonalds JA, Strom BL et al. A Case-control study of body mass index and breast cancer risk in white and African-American women. Cancer Epidemiol Biomarkers Prev 2010; 19:1532-1544.
6. Braaten T, Weiderpass E, Kumle M, Adami HO, Lund E. Education and risk of breast cancer in the Norwegian-Swedish women's lifestyle and health cohort study. Int J Cancer 2004;110:579-583. (Pubitemid 38658023)
7. Crosignani PG, Colombo M, Vegetti W, Somigliana E, Gessati A, Ragni G. Overweight and obese anovulatory patients with polycystic ovaries: Parallel improvements in anthropometric indices, ovarian physiology and fertility rate induced by diet. Hum Reprod 2003;18:1928-1932. (Pubitemid 37107570)
8. Dearth RK, Delgado DA, Hiney JK, Pathiraja T, Oesterreich S, Medina D, Dees WL, Lee AV. Parity-induced decrease in systemic growth hormone alters mammary gland signaling: A potential role in pregnancy protection from breast cancer. Cancer Prev Res 2010; 3:312-321.
9. Durante KM, Li NP. Oestradiol level and opportunistic mating in women. Bio Lett 2009;5:179-182.
10. Eliassen AH, Missmer SA, Tworoger SS, Spiegelman D, Barbieri RL, Dowsett M, Hankinson SE. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women. J Natl Cancer Inst 2006;98:1406-1415. (Pubitemid 44530717)
11. Ellison PT, Lipson SF. Salivary estradiol- a viable alternative? Fertil Steril 1999;72:951-952.
12. Emaus A. PhD-thesis. Metabolic profile, physical activity, estradiol and breast cancer. Faculty of Medicine, University of Oslo, 2009, Norway. ISBN 978-82-8072-320-8, 2009.
13. Emaus A, Espetvedt S, Veierød MB, Ballard-Barbash R, Furberg AS, Ellison PT, Jasienska G, Hjartåker A, Thune I. 17b-Estradiol in relation to age at menarche and adult obesity in premenopausal women. Hum Reprod 2008a;23:919-927.
14. Emaus A, Veierød MB, Furberg AS, Espetvedt S, Friedenreich C, Ellison PT, Jasienska G, Andersen LB, Thune I. Physical activity, heart rate, metabolic profile, and estradiol in premenopausal women. Med Sci Sports Exerc 2008b;40:1022-1030.
15. Endogenous Hormones and Breast Cancer Collaborative Group. Endogenous sex hormones and breast cancer in postmenopausal women: Reanalysis of nine prospective studies. J Natl Cancer Inst 2002; 94:606-616.
16. Finstad SE, Emaus A, Potischman N, Barrett E, Furberg AS, Ellison PT, Jasienska G, Thune I. Influence of birth weight and adult body composition on 17beta-estradiol levels in young women. Cancer Causes Control 2009a;20:233-242.
17. Finstad SE, Emaus A, Tretli S, Jasienska G, Ellison PT, Furberg AS, Wist EA, Thune I. Adult height, insulin, and 17beta-estradiol in young women. Cancer Epidemiol Biomarkers Prev 2009b;18:1477-1483.
18. Friedenreich CM. Review of anthropometric factors and breast cancer risk. Eur J Cancer Prev 2001;10:15-32. (Pubitemid 32200199)
19. Furberg AS, Jasienska G, Bjurstam N, Torjesen PA, Emaus A, Lipson SF, Ellison PT, Thune I. Metabolic and hormonal profiles: HDL cholesterol as a plausible biomarker of breast cancer risk. The Norwegian EBBA Study. Cancer Epidemiol Biomarkers Prev 2005; 14:33-40. (Pubitemid 40165280)
20. Gann PH, Giovanazzi S, Horn LV, Branning A, Chatterton RT. Saliva as a medium for investigating intra-and interindividual differences in sex hormone levels in premenopausal women. Cancer Epidemiol Biomarkers Prev 2001;10:59-64. (Pubitemid 32106045)
21. Hunter DJ, Colditz GA, Hankinson SE, Malspeis S, Spiegelman D, ChenW, Stampfer MJ, Willett WC. Oral contraceptive use and breast cancer: A prospective study of young women. Cancer Epidemiol Biomarkers Prev 2010;19:2496-2502.
22. IARC Handbook of Cancer Prevention. Weight Control and Physical Activity, Vol. 6. Lyon, France: IARC Press, 2002.
23. Jasienska G, Thune I. Lifestyle, hormones and risk of breast cancer. Br Med J 2001;322:586-587. (Pubitemid 32234534)
24. Jasienska G, Ziomkiewicz A, Lipson SF, Thune I, Ellison PT. High ponderal index at birth predicts high estradiol levels in adult women. Am J Hum Biol 2006a;18:133-140. (Pubitemid 43137101)
25. Jasienska G, Kapiszewska M, Ellison PT, Kalemba-Drozdz M, Nenko I, Thune I, Ziomkiewicz A. CYP17 genotypes differ in salivary 17b-Estradiol levels: A study based on hormonal profiles from entire menstrual cycles. Cancer Epidemiol Biomarkers Prev 2006b;18:133-140.
26. Jasienska G, Ziomkiewicz A, Thune I, Lipson SF, Ellison PT. Habitual physical activity and estradiol levels in women of reproductive age. Eur J Cancer Prev 2006c;15:439-445. (Pubitemid 44252915)
27. Jasisenska G, Jasienski M. Inter-population, inter-individual, inter-cycle, and intra-cycle natural variation in progesterone levels: A quantitative assessment and implications for population studies. Am J Hum Biol 2008;20:35-42.
28. Kaaks R, Berrino F, Key T, Rinaldi S, Dossus L, Biessy C, Secreto G, Amiano P, Bingham S, Boeing H et al. Serum sex steroids in premenopausal women and breast cancer risk within the European prospective investigation into cancer and nutrition (EPIC). J Natl Cancer Inst 2005;97:755-765. (Pubitemid 40879595)
29. Kaplowitz P. Pubertal development in girls: Secular trends. Curr Opin Obstet Gynecol 2006;18:487-491. (Pubitemid 44319019)
30. Lambe M, Hsieh C, Trichopoulos D, Ekbom A, Pavia M, Adami HO. Transient increase in the risk of breast cancer after giving birth. N Engl J Med 1994;331:5-9. (Pubitemid 24195593)
31. Li CI, Malone KE, Daling JR, Potter JD, Bernstein L, Marchbanks PA, Strom BL, Simon MS, Press MF, Ursin G et al. Timing of menarche and first full-term birth in relation to breast cancer risk. Am J Epidemiol 2008;167:230-239.
32. Lillegaard IT, Overby NC, Andersen LF. Can children and adolescents use photographys of food to estimate portion sizes? Eur J Clin Nutr 2005; 59:611-617. (Pubitemid 40528677)
33. Lipson SF, Ellison PT. Comparison of salivary steroid profiles in naturally occurring conception and non-conception cycles. Hum Reprod 1996; 11/10:2090-2096. (Pubitemid 26391993)
34. Lund E, Bakken K, Dumeaux V, Andersen V, Kumle M. Hormone replacement therapy and breast cancer in former users of oral contraceptives-The Norwegian women and cancer study. Int J Cancer 2007;121:645-648. (Pubitemid 46986499)
35. Ma H, Bernstein L, Pike MC, Ursin G. Reproductive factors and breast cancer risk according to joint estrogen and progesterone receptor status: A meta-analysis of epidemiological studies. Breast Cancer Res 2006;8:1-11.
36. MacMahon B, Cole P, Lin TM, Lowe CR, Mirra AP, Ravnihar B, Salber EJ, Valaoras CG, Yuasa S. Age at first birth and breast cancer risk. Bull World Health Organ 1970;43:209-221.
37. Matthews JNS, Altman DG, Campbell MJ, Royston P. Analysis of serial measurements in medical research. Br Med J 1990;300:230-235. (Pubitemid 20045528)
38. McDougall JA, Sakata R, Sugiyama H, Grant E, Davis S, Nishi N, Soda M, Shimizu Y, Tatsukawa Y, Kasagi F et al. Timing of Menarche and First Birth in Relation to Risk of Breast Cancer in A-Bomb Survivors. Cancer Epidemiol Biomarkers Prev 2010;19:1746-1754.
39. McTiernan A, Wu LL, Chen C, Chlebowski R, Mossavar-Rahmani Y, Modugno F, Perri MG, Stanczyk FZ, Van Horn L, Wang CY. Women's Health Initiative Investigators. Relation of BMI and physical activity to sex hormones in postmenopausal women. Obesity 2006; 14:1662-1677. (Pubitemid 46214834)
40. Miller KK, Grinspoon S, Gleysteen S, Grieco KA, Ciampa J, Breu J, Herzog DB, Klibanski A. Preservation of neuroendocrine control of reproductive function despite severe undernutrition. J Clin Endocrinol Metab 2004;89:4434-4438. (Pubitemid 39244451)
41. Panter-Brick C, Lotstein DS, Ellison PT. Seasonality of reproductive function and weight loss in rural Nepali women. Hum Reprod 1993; 8:684-690. (Pubitemid 23164281)
42. Pawlowski B, Jasienska G. Womens preferences for sexual dimorphism in height depend on menstrual cycle phase and expected duration of relationship. Biol Psychol 2005;70:38-43. (Pubitemid 40982647)
43. Pike MC, Spicer DV, Dahmoush L, Press MF. Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. Epidemiol Rev 1993;15:17-35. (Pubitemid 23269068)
44. Prentice RL, Chlebowski RT, Stefanick ML, Manson JE, Pettinger M, Hendrix SL, Hubbell FA, Kooperberg C, Kuller LH, Lane DS et al. Estrogen Plus Progestin Therapy and Breast Cancer in Recently Postmenopausal Women. Am J Epidemiol 2008;167:1207-1216. (Pubitemid 351670642)
45. Russo J, Tay LK, Russo IH. Differentiation of the mammary gland and susceptibility to carcinogenesis. Breast Cancer Res Treat 1982; 2:5-73. (Pubitemid 12017450)
46. Speroff L, Fritz MA. Clinical gynecologic endocrinology and infertility, 7th edn. Lippincott Williams & Wilkins, Philadelphia, PA, 2005.
47. Trichopoulos D, Hsieh CC, MacMahon B, Lin TM, Lowe CR, Mirra AP, Ravnihar B, Salber EJ, Valaoras VG, Yuasa S. Age at any birth and breast cancer risk. Int J Cancer 1983;31:701-704. (Pubitemid 13060771)
48. Tworoger SS, Missmer SA, Eliassen AH, Barbieri RL, Dowsett M, Hankinson SE. Physical activity and inactivity in relation to sex hormone, prolactin, and insulin-like growth factor concentrations in premenopausal women-exercise and premenopausal hormones. Cancer Causes Control 2007;18:743-752. (Pubitemid 46988242)
49. Venners SA, Liu X, Perry MJ, Korrick SA, Li Z, Yang F, Yang J, Lasley BL, Xu X, Wang X. Urinary estrogen and progesterone metabolite concentrations in menstrual cycles of fertile women with non-conception, early pregnancy loss or clinical pregnancy. Hum Reprod 2006;21:2272-2280. (Pubitemid 44530600)
50. Verkasalo PK, Thomas HV, Appleby PN, Davey GK, Key TJ. Circulating levels of sex hormones and their relation to risk factors for breast cancer: A cross-sectional study in 1092 pre- and postmenopausal women (United Kingdom). Cancer Causes Control 2001;12:47-59. (Pubitemid 32125900)
51. World Cancer Research Fund/American Institute for Cancer Research. Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective. Washington, DC: AICR, 2007.
52. Ziomkiewicz A, Ellison PT, Lipson SF, Thune I, Jasienska G. Body fat, energy balance and estradiol levels: A study based on hormonal profiles from complete menstrual cycles. Hum Reprod 2008; 11:2555-2563.